TABLE 1.
Comparison of demographic characteristics, clinical information, and outcomes of patients with C. gleum and C. indologenes infections
| Parameter | Value for the parameter |
OR (95% CI)a | P value | ||
|---|---|---|---|---|---|
| Total group (n = 126) | C. gleum (n = 42) | C. indologenes (n = 84) | |||
| Sex (no. of patients [%]) | |||||
| Male | 86 (68.3) | 27 (64.3) | 59 (70.2) | 0.76 (0.35–1.67) | 0.499 |
| Female | 40 (31.7) | 15 (35.7) | 25 (29.8) | 1.31 (0.6–2.88) | 0.499 |
| Age (yr) | |||||
| Range | 13–91 | 20–91 | 13–90 | ||
| Median | 59.5 | 58.5 | 62 | ||
| Mean ± standard deviation | 59 ± 19.2 | 58.8 ± 16.5 | 59.1 ± 20.4 | 0.913 | |
| Comorbidity (no. of patients [%]) | 103 (81.7) | 36 (85.7) | 67 (79.8) | 1.52 (0.55–4.2) | 0.415 |
| Diabetes mellitus | 48 (38.1) | 13 (31) | 35 (41.7) | 0.63 (0.29–1.38) | 0.243 |
| Cardiovascular disease | 59 (46.8) | 17 (40.5) | 42 (50) | 0.68 (0.32–1.44) | 0.313 |
| End-stage renal disease (no. of patients [%]) | 5 (4) | 1 (2.4) | 4 (4.8) | 0.49 (0.05–4.51) | 0.664 |
| Malignancy | 42 (33.3) | 21 (50) | 21 (25) | 3 (1.37–6.55) | 0.005 |
| Liver cirrhosis | 20 (15.9) | 13 (31) | 7 (8.3) | 4.93 (1.79–13.58) | 0.001 |
| Chronic obstructive pulmonary disease | 10 (7.9) | 2 (4.8) | 8 (9.5) | 0.48 (0.1–2.34) | 0.494 |
| Type of infection acquisition (no. of patients [%]) | |||||
| Community-acquired infection | 1 (0.8) | 0 | 1 (1.2) | 0.999 | |
| Health care-associated infection | 125 (99.2) | 42 (100) | 83 (98.8) | 1.51 (1.33–1.71) | 0.999 |
| Laboratory data | |||||
| White blood cell count (cells/mm3) | 14,039 ± 39,343 | 9,578 ± 5,697 | 16,270 ± 47,959 | 0.37 | |
| Hemoglobin (g/dl) | 10.4 ± 2.3 | 10.8 ± 2.1 | 10.2 ± 2.4 | 0.187 | |
| Platelet count (×103 cells/mm3) | 198,629 ± 120,124 | 212,905 ± 108,507 | 191,492 ± 125,542 | 0.348 | |
| Serum creatinine (mg/dl) | 1.7 ± 1.5 | 1.6 ± 1.7 | 1.8 ± 1.4 | 0.487 | |
| Shock (no. of patients [%]) | 42 (33.3) | 6 (14.3) | 36 (42.9) | 0.22 (0.09–0.58) | 0.001 |
| Admission to intensive care unit (no. of patients [%]) | 45 (35.7) | 5 (11.9) | 40 (47.6) | 0.15 (0.05–0.42) | <0.001 |
| Inappropriate empirical antimicrobial therapy (no. of patients [%]) | 112 (88.9) | 38 (90.5) | 74 (88.1) | 1.28 (0.38–4.37) | 0.688 |
| Outcome | |||||
| Case fatality (no. [%]) | 25 (19.8) | 4 (9.5) | 21 (25) | 0.32 (0.1–0.99) | 0.04 |
a
OR, odds ratio; CI, confidence interval.